We next determined whether ddPCR could detect blood TAA in patients who had evidence of residual acute leukemia after HCT by standard of care tests (marrow flow cytometry, BCR-ABL testing, or cytogenetic abnormalities). This evidence concerns the gene ABL1 and acute leukemia.